BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Free cash flow 2018–2024
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$62.3MFY2024 · since FY2018: -$8.5M → -$62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$62.3M | +6.7% |
| FY2023 | -$66.8M | +21.7% |
| FY2022 | -$85.3M | +17.1% |
| FY2021 | -$102.9M | -96.7% |
| FY2020 | -$52.3M | -111.7% |
| FY2019 | -$24.7M | -189.5% |
| FY2018 | -$8.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BDTX financial trends
BDTX RevenueBDTX Net incomeBDTX Net marginBDTX Gross profitBDTX Gross marginBDTX Operating incomeBDTX Operating marginBDTX Operating cash flowBDTX Capital expendituresBDTX Return on equityBDTX Stock buybacksBDTX Dividends paidBDTX Total assetsBDTX Total liabilitiesBDTX Shareholders’ equityBDTX overview →